ClinicalTrials.Veeva

Menu

Change in Brain Metabolism and Cognitive Function by Aripiprazole

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Dopamine Receptor Occupancy
Brain Metabolism
Cognition
Antipsychotics

Treatments

Drug: Aripiprazole

Study type

Interventional

Funder types

Other

Identifiers

NCT01562808
A070001 (Other Grant/Funding Number)

Details and patient eligibility

About

Dopamine receptor occupancy and brain metabolism were measured using positron emission tomography after the administration of aripiprazole. Working memory performance was also measured using N-back task.

The investigators explored the relationship between changes in brain metabolism and working memory performance.

Enrollment

15 patients

Sex

Male

Ages

19 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy volunteers
  • right-handed

Exclusion criteria

  • any significant abnormality on routine lab
  • any psychiatric disease

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems